Yes, catalysis can be employed in targeted drug delivery systems. One approach involves using catalytic nanoparticles that are designed to activate a drug at the specific site of disease within the body. This method can increase the efficacy of the drug while reducing side effects. For example, platinum-based nanoparticles have been explored for their potential to catalyze the conversion of prodrugs into active drugs at the tumor site in cancer therapy.
